Valentine's Day can be a challenging holiday for those experiencing vision difficulties due to macular degeneration, but you can still make it special and meaningful with a little adaptation and creativity.
IZERVAY, a new complement C5 inhibitor, is now FDA-approved for treating GA due to AMD. Studies showed a reduction in the rate of GA growth and risk of vision loss.
Drusen are common in aging adults over the age of 50. While drusen alone don't signify macular degeneration, people with larger or numerous drusen have an increased risk.
The Amsler grid is a simple tool for monitoring vision in conditions like age-related macular degeneration (AMD). It helps detect distortions and visual impairment, allowing for timely intervention.
If you have AMD, you should inform your family, educate yourself, monitor for progression, make lifestyle modifications, and understand available treatments for AMD – early detection and intervention are crucial.
Studies showed anti-VEGF injections in wet AMD didn’t increase the risk of developing glaucoma, but people with both wet AMD and glaucoma had an elevated likelihood of visual field progression.
Myopic macular degeneration (MMD) is not the same as age-related macular degeneration (AMD). MMD primarily affects younger individuals with high myopia.
